(Q44604233)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healthy women (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Aliana Guerrieri Gonzaga

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

B Bonanni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

H Johansson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

M T Sandri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

F Mariette

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

E A Lien

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

A Decensi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Haemostasis

19 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

2149-2152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14521597%20AND%20SRC:MED&resulttype=core&format=json

Overview of the main outcomes in breast-cancer prevention trials

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Tamoxifen for breast cancer among hysterectomised women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Structure and function of the pentraxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Coronary heart disease mortality and adjuvant tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Tamoxifen reduces plasma homocysteine levels in healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Biologic Activity of Tamoxifen at Low Doses in Healthy Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00392.X